Follow-The-Filings

Security · featured owners

MAZE

Maze Therapeutics Inc. COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.4%
  • $35M
  • 2 add

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (Nathan Fischel - Dafna Ca...) · not free-float ownership

  1. Nathan Fischel add 0.4%
  2. Farallon Capital Management add 0.2%

holders

sorted by % of portfolio · long equity only · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.4% Add +85.7% 65,000 $2M hist
Farallon Capital Management 2026 Q2 0.2% Add +197.0% 1,107,814 $33M hist

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2025
Revenue —
Gross profit —
Gross margin —
Net income -$131.12M
Net margin —

Balance sheet

Metric FY2025
Total current assets $349.72M
Total non-current assets * $47.41M
Total assets $397.13M
Total current liabilities $22.56M
Total non-current liabilities * $19.6M
Total equity $354.97M

Cash flow

Metric FY2025
Cash from operations -$111.94M
Cash from investing -$170.96M
Cash from financing $275.34M
Net change in cash * -$7.56M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders